- Founder(s): Dr. Albrecht Läufer & Markus Fehr
- Established: June 2017
- CEO(s): Dr. Albrecht Läufer & Markus Fehr
- Employees: 9
- Website: https://blucon-biotech.com/
BluCon Biotech GmbH provides a unique technology by which L-lactic acid can be produced with the lowest possible production costs. This will enable the bioplastic PLA (poly lactic acid), the polymer of L-lactic acid, to become commercially competitive to fossil fuel based plastics and convert millions of tons of non-degradable plastic waste into biodegradable, environmentally friendly products.
The unique technology of BluCon Biotech GmbH enables consolidated bioprocessing (CBP) of cheap non-food cellulosic or lignocellulosic feedstock to create a one step L-lactic acid process using thermophilic bacteria. Using modern strains and bioprocess engineering, BluCon Biotech GmbH is currently driving its technology to commercialization.
BluCon Biotech GmbH has its research laboratories and offices at the BioCampus in Cologne. The location provides all infrastructure and networks to extend and commercialize the company’s biotechnology platform.